The clinical research for Ganoderan's effect on preventing and treating cerebral arteriosclerosis through inhibiting NADPH oxidizing enzyme expression

Journal Title: Pakistan Journal of Pharmaceutical Sciences - Year 2014, Vol 27, Issue 4

Abstract

 A lot of researches have verified that produced excessive reactive oxygen is one of the hazard factors causing atherosclerosis. NADPH oxidase is the main protease of vascular cell’s producing reactive oxygen, the expression of its relevant subunits is closely correlated with the occurring and development process of atherosclerosis. Oxidizing reaction could damage organism tissue cells, ganoderan has very significant effect on the anti-oxidizing function of cell. The pharmaceutical research of ganoderan has significant meaning in curing diabetes mellitus, preventing and controlling arteriosclerosis. This paper is mainly to discuss the effect of anoderan's inhibiting NADPH oxidizing enzyme expression on preventing and treating cerebral arteriosclerosis and its action mechanism.

Authors and Affiliations

Zhang Li Feng , Teng Jun Fang , Yuan Xue Qian , Wang Huan Rong

Keywords

Related Articles

 Enhanced Ehrlich tumor inhibition using DOX-NP and gold nanoparticles loaded liposomes

 Treatment with doxorubicin (DOX) is a common treatment for different types of cancer. DOX-NP is one of a well established marketed liposomal formulation for DOX. It has advantages over free DOX in reducing the card...

 Studies on nano-additive for the substitution of hazardous chemical substances in antifouling coatings for the protection of ship hulls

 Adhesion and growth of biofouling organisms have severe influence on the reliability, service life and environmental adaptability of marine ships. Based on the bactericidal capacity of cuprous oxide and photochemic...

 Unpredictable chronic mild stress induced behavioral deficits: A comparative study in male and female rats

 Stress is an important precipitant factor for depression. Changes in various body systems that occur in depression are similar to those observed in response to stress. Chronic stress may alter behavioral, neurochem...

 Disintegrants combination: Development and optimization of a cefadroxil fast disintegrating tablet

 Fast Disintegrating Tablets (FDTs) is a rapidly growing dosage form preferred for special population (pediatric, geriatric and psychotic patients). It is also developed with the aim of improving bioavailability and...

 Evaluation of anti-hyperglycemic effect of Actinidia kolomikta (Maxim. etRur.) Maxim. root extract

 This study aimed to evaluate the anti-hyperglycemic effect of ethanol extract from Actinidia kolomikta (Maxim. etRur.) Maxim. root (AKE).An in vitro evaluation was performed by using rat intestinal α-glucosidase (m...

Download PDF file
  • EP ID EP99754
  • DOI -
  • Views 87
  • Downloads 0

How To Cite

Zhang Li Feng, Teng Jun Fang, Yuan Xue Qian, Wang Huan Rong (2014).  The clinical research for Ganoderan's effect on preventing and treating cerebral arteriosclerosis through inhibiting NADPH oxidizing enzyme expression. Pakistan Journal of Pharmaceutical Sciences, 27(4), 1107-1111. https://europub.co.uk/articles/-A-99754